Back to GetFilings.com




 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


 

Form 10-Q

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                      to                     .

 

Commission file number—333-56097

 


 

RIVER HOLDING CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   95-4674065

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

599 Lexington Drive, 18th Floor

New York, New York

 

10022

(Address of Principal Executive Offices)   (Zip Code)

 

(212) 758-2555

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report).

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ¨    Not Applicable  x

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined by Rule 12b-2 of the Exchange Act). Yes  ¨    No  x

 

The number of shares of Common Stock, $0.01 par value, outstanding (the only class of common stock of the Company outstanding) was 9,069,293 on May 7, 2004.

 


 


RIVER HOLDING CORP. AND SUBSIDIARIES

 

QUARTER ENDED MARCH 31, 2004

 

TABLE OF CONTENTS

 

              Page

PART I   FINANCIAL INFORMATION     
    Item 1.    River Holding Corp. Unaudited Condensed Consolidated Financial Statements:     
         Unaudited Condensed Consolidated Balance Sheets as of March 31, 2004 and December 31, 2003    1
         Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2004 and March 31, 2003    3
         Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2004 and March 31, 2003    4
         Notes to Unaudited Condensed Consolidated Financial Statements    6
         Hudson Respiratory Care Inc. Unaudited Condensed Consolidated Financial Statements:     
         Unaudited Condensed Consolidated Balance Sheets as of March 31, 2004 and December 31, 2003    12
         Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2004 and March 31, 2003    14
         Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2004 and March 31, 2003    15
         Notes to Unaudited Condensed Consolidated Financial Statements    17
    Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations    23
    Item 3.    Quantitative and Qualitative Disclosures About Market Risks    27
    Item 4.    Controls and Procedures    27
PART II   OTHER INFORMATION     
    Item 1.    Legal Proceedings    27
    Item 2.    Changes in Securities    27
    Item 3.    Defaults Upon Senior Securities    27
    Item 4.    Submission of Matters to a Vote of Security Holders    27
    Item 5.    Other Information    27
    Item 6.    Exhibits and Reports on Form 8-K    27
SIGNATURE    29

 

i


RIVER HOLDING CORP. AND SUBSIDIARIES

 

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

 

ASSETS

 

(amounts in thousands)

 

    

March 31,

2004


  

December 31,

2003


CURRENT ASSETS:

             

Cash

   $ 6,299    $ 6,682

Accounts receivable, less allowance for doubtful accounts of $1,217 and $1,156 at March 31, 2004 and December 31, 2003, respectively

     27,319      25,107

Inventories, net

     24,074      23,829

Other current assets

     2,455      2,505
    

  

Total current assets

     60,147      58,123

PROPERTY, PLANT AND EQUIPMENT, net

     41,048      41,154

GOODWILL

     39,822      41,410

DEFERRED FINANCING AND OTHER COSTS, net of accumulated amortization of $5,457 and $5,188 at March 31, 2004 and December 31, 2003, respectively

     6,169      6,457

OTHER ASSETS

     581      536
    

  

Total other assets

     46,572      48,403
    

  

Total assets

   $ 147,767    $ 147,680
    

  

 

 

 

See notes to condensed consolidated statements

 

1


RIVER HOLDING CORP. AND SUBSIDIARIES

 

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

(amounts in thousands, except per share amounts)

 

    

March 31,

2004


   

December 31,

2003


 

CURRENT LIABILITIES:

                

Current portion of bank notes payable

   $ 8,968     $ 9,178  

Accounts payable

     10,652       9,175  

Accrued liabilities

     17,714       16,973  
    


 


Total current liabilities

     37,334       35,326  

INTEREST PAYABLE TO AFFILIATES

     11,161       9,760  

NOTES PAYABLE TO AFFILIATES

     39,317       39,317  

BANK NOTES PAYABLE, net of current portion

     50,176       54,377  

SENIOR SUBORDINATED NOTES PAYABLE

     115,000       115,000  

MANDATORILY REDEEMABLE PREFERRED STOCK, $0.01 par value; 2,990 shares authorized; 556 shares issued and outstanding at March 31, 2004 and December 31, 2003; liquidation preference, $58,550

     55,166       55,147  

Accrued preferred stock dividend, payable in kind

     2,932       1,333  
    


 


       58,098       56,480  

OTHER NON-CURRENT LIABILITIES

     2,237       2,316  
    


 


Total liabilities

     313,323       312,576  

COMMITMENTS AND CONTINGENCIES (Note 4)

                

STOCKHOLDERS’ DEFICIT:

                

Junior preferred stock, $0.01 par value; 10 shares authorized; 3 shares outstanding at March 31, 2004 and December 31, 2003

     4,076       3,960  

Common stock, $0.01 par value; 42,000 shares authorized; 9,144 issued and 9,069 outstanding at March 31, 2004 and December 31, 2003

     97,848       97,848  

Additional paid in capital

     881       881  

Treasury stock, at cost, 75 shares at March 31, 2004 and December 31, 2003

     (75 )     (75 )

Cumulative translation adjustment

     5,973       7,312  

Accumulated deficit

     (274,259 )     (274,822 )
    


 


Total stockholders’ deficit

     (165,556 )     (164,896 )
    


 


Total liabilities and stockholders’ deficit

   $ 147,767     $ 144,710  
    


 


 

See notes to condensed consolidated statements

 

2


RIVER HOLDING CORP. AND SUBSIDIARIES

 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(amounts in thousands)

 

     Three Months Ended

 
    

March 31,

2004


   

March 31,

2003


 

NET SALES

   $ 50,183     $ 45,879  

COST OF SALES

     26,786       26,586  
    


 


Gross Profit

     23,397       19,293  

OPERATING EXPENSES:

                

Distribution, selling, general & administrative

     14,106       12,757  

Research and development

     859       640  
    


 


       14,965       13,397  
    


 


Income from operations

     8,432       5,896  

INTEREST EXPENSE AND OTHER, net

     7,080       5,261  
    


 


Net income before provision for income taxes

     1,352       635  

PROVISION FOR INCOME TAXES

     674       681  
    


 


Net income (loss)

   $ 678     $ (46 )
    


 


OTHER COMPREHENSIVE (LOSS) INCOME:

                

Foreign currency translation (loss) gain

     (1,339 )     721  
    


 


Comprehensive (loss) income

   $ (661 )   $ 675  
    


 


 

See notes to condensed consolidated statements

 

3


RIVER HOLDING CORP. AND SUBSIDIARIES

 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

(amounts in thousands)

 

     Three Months Ended

 
    

March 31,

2004


   

March 31,

2003


 

CASH FLOWS FROM OPERATING ACTIVITIES:

                

Net income (loss)

   $ 678     $ (46 )

Adjustments to reconcile net income (loss) to net cash provided by operating activities-

                

Depreciation and amortization

     3,037       2,961  

Amortization of deferred financing costs

     269       464  

Accrued mandatorily redeemable preferred stock dividends, payable in-kind

     1,618       —    

Interest payable to affiliates

     1,402       1,064  

Provision for bad debts

     88       197  

Loss (gain) on disposal of property, plant and equipment

     11       (6 )

Changes in operating assets and liabilities:

                

Accounts receivable

     (2,618 )     342  

Inventories

     (422 )     1,413  

Other current assets

     13       (799 )

Other assets

     (46 )     (19 )

Accounts payable

     1,543       (625 )

Accrued liabilities

     885       2,047  

Other non-current liabilities

     18       12  
    


 


Net cash provided by operating activities

     6,476       7,005  

CASH FLOWS FROM INVESTING ACTIVITIES:

                

Purchases of property, plant and equipment

     (3,024 )     (1,723 )

Proceeds from sales of property, plant and equipment

     2       17  
    


 


Net cash used in investing activities

     (3,022 )     (1,706 )

CASH FLOWS FROM FINANCING ACTIVITIES:

                

Repayment of bank notes payable

     (4,317 )     (7,734 )

Proceeds from bank borrowings

     408       1,582  

Payment of capital lease obligations

     (14 )     (13 )
    


 


Net cash used in financing activities

     (3,923 )     (6,165 )

Effect of exchange rate changes on cash

     86       (292 )
    


 


NET DECREASE IN CASH

     (383 )     (1,158 )

CASH, beginning of period

     6,682       6,425  
    


 


CASH, end of period

   $ 6,299     $ 5,267  
    


 


 

See notes to condensed consolidated statements

 

4


     Three Months Ended

    

March 31,

2004


  

March 31,

2003


SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

             

Cash paid during the period for:

             

Interest

   $ 932    $ 1,076
    

  

Income taxes (primarily foreign)

   $ 365    $ 1,138
    

  

NON-CASH FINANCING ACTIVITIES:

             

Preferred dividends accrued or paid-in-kind

   $ 116    $ 1,533
    

  

 

See notes to condensed consolidated statements

 

 

5


RIVER HOLDING CORP. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. Financial Statements. River Holding Corp. (“Holding”) is a holding company with no other operations than those of its majority owned subsidiary, Hudson Respiratory Care Inc. (“Hudson” or the “Company”). The condensed consolidated financial statements included herein have been prepared by Holding and Hudson, without audit, and include all adjustments which are, in the opinion of management, necessary for a fair presentation of the financial position at March 31, 2004, the results of operations for the three month period ended March 31, 2004 and March 31, 2003 and statements of cash flows for the three month period ended March 31, 2004 and March 31, 2003 pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. Although Holding believes that the disclosures in such financial statements are adequate to make the information presented not misleading, the accompanying unaudited condensed consolidated financial statements should be read in conjunction with Holding’s 2003 audited financial statements and the notes thereto included in its Form 10-K filed with the SEC. The results of operations for the three month period ended March 31, 2004 are not necessarily indicative of the results to be achieved for a full year.

 

Significant Accounting Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

The significant estimates made in the preparation of the Company’s consolidated financial statements relate to allowance for bad debts, rebate reserve, and inventory reserve.

 

Stock Based Compensation

 

Holding accounts for its stock-based compensation plans under the recognition and measurement principles of Accounting Principles Board Opinion (“APB”) 25, “Accounting for Stock Issued to Employees,” and related interpretations. Holding has adopted the disclosure provisions of Statement Financial Accounting Standards (“SFAS “) 123, “Accounting for Stock-Based Compensation,” as amended by SFAS 148, “Accounting for Stock-Based Compensation – Transition and Disclosure – an amendment of FASB Statement No. 123.” No stock-based employee compensation expense is recognized in net income for any of the periods presented. Had compensation expense for Holding’s stock-based compensation awards been recognized based on the fair value recognition provisions of SFAS 123, Holding’s net income would have been adjusted to the pro forma amounts indicated below (amounts in thousands):

 

    

Three Months
Ended

March 31,


 
     2004

   2003

 

Net income (loss), as reported

   $ 678    $ (46 )

Deduct: Total stock-based employee compensation expense determined under the fair value based method for all awards

     33      3  
    

  


Pro forma net income (loss)

   $ 645    $ (49 )
    

  


 

Stock Based Compensation

 

Under the fair-value method, compensation expense is measured at the grant date based on the fair value of the award using an option-pricing model. Compensation expense is recognized on a straight-line basis over the vesting period. The fair value of employee stock options was estimated using the Black-Scholes option-pricing model with the following weighted-average assumptions used for grants in 2003 and 2002: risk-free interest rates of

 

6


2.00% and 2.83%, respectively; dividend yield of 0% for all years; expected lives of three years and four years, respectively, and volatility of 50% for both years.

 

Reclassifications

 

Certain amounts from prior periods have been reclassified to conform to the current period presentation.

 

2. Inventories. Inventories consisted of the following (amounts in thousands):

 

    

March 31,

2004


  

December 31,

2003


Raw materials

   $ 4,587    $ 4,558

Work-in-process

     5,113      4,955

Finished goods

     14,374      14,316
    

  

     $ 24,074    $ 23,829
    

  

 

3. Geographic and Segment Information. Holding presents segment information externally based on how management uses financial data internally to make operating decisions and assess performance. Holding has two operating segments: guarantor, primarily the United States and non-guarantor, primarily international. The non-guarantor subsidiaries consist principally of Hudson AB and subsidiaries (whose operations are principally international). Under SFAS 131, “Disclosures about Segments of an Enterprise and Related Information,” Holding’s operating segments are the same as its reporting segments.

 

Holding sells respiratory care and anesthesia products to distributors and medical facilities throughout the United States and internationally. Operating results of Holding’s various product groups have been aggregated because of their common characteristics and their reliance on shared operating functions. Holding operates primarily in the United States and in Europe.

 

Holding’s sales and percentage of sales by geographic region for the three months ending March 31, 2004 and 2003 are as follows (amounts in thousands):

 

     Three Months Ended

 
     March 31, 2004

    March 31, 2003

 

United States

   $ 34,454    68.6 %   $ 33,573    73.2 %

Europe

     9,824    19.6       7,052    15.4  

Pacific Rim (Japan, Southeast Asia, Australia/New Zealand)

     3,140    6.3       3,355    7.3  

Canada

     794    1.6       564    1.2  

Other international

     1,971    3.9       1,335    2.9  
    

  

 

  

     $ 50,183    100.0 %   $ 45,879    100.0 %
    

  

 

  

 

Holding’s sales and percentage of sales by product group for the three months ending March 31, 2004, and 2003 are as follows (amounts in thousands):

 

     Three Months Ended

 
     March 31, 2004

    March 31, 2003

 

Oxygen Therapy

   $ 14,897    29.7 %   $ 13,264    28.9 %

Airway Management

     11,834    23.6       11,803    25.7  

Humidification

     11,464    22.8       10,676    23.3  

Aerosol Therapy

     11,987    23.9       10,136    22.1  
    

  

 

  

     $ 50,183    100.0 %   $ 45,879    100.0 %
    

  

 

  

 

7


The Company is the 100% owner of certain subsidiaries that do not guarantee the Company’s senior subordinated notes and certain bank debt. The following tables disclose required consolidating financial information for guarantor and non-guarantor subsidiaries (amounts in thousands):

 

RIVER HOLDING CORP. AND SUBSIDIARIES

GUARANTOR AND NON-GUARANTOR SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEETS

 

ASSETS

 

     March 31, 2004

     River

   Guarantor

  

Non-

Guarantor


   Eliminations

    Total

CURRENT ASSETS:

                                   

Cash

   $ —      $ 3,887    $ 2,412    $ —       $ 6,299

Accounts receivable

     —        18,897      8,422      —         27,319

Intercompany receivables, net

     —        —        1,169      (1,169 )     —  

Inventories

     —        20,946      4,432      (1,304 )     24,074

Other current assets

     —        1,499      956      —         2,455
    

  

  

  


 

Total current assets

     —        45,229      17,391      (2,473 )     60,147

PROPERTY, PLANT AND EQUIPMENT, NET

     3,121      35,841      2,086      —         41,048

GOODWILL

     —        —        39,822      —         39,822

DEFERRED FINANCING AND OTHER ASSETS, net

     —        6,169      —        —         6,169

INVESTMENT IN NON-GUARANTOR SUBSIDIARIES, at cost

     —        28,636      4,000      (32,636 )     —  

OTHER ASSETS

     13      1,262      26      (720 )     581
    

  

  

  


 

Total other assets

     13      36,067      43,848      (33,356 )     46,572
    

  

  

  


 

     $ 3,134    $ 117,137    $ 63,325    $ (35,829 )   $ 147,767
    

  

  

  


 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

CURRENT LIABILITIES:

                                      

Current portion of bank notes payable

   $ —      $ 3,680     $ 5,288    $ —       $ 8,968  

Accounts payable

     —        9,098       1,554      —         10,652  

Intercompany payables, net

     —        1,169       —        (1,169 )     —    

Accrued liabilities

     —        13,995       3,719      —         17,714  
    

  


 

  


 


Total current liabilities

     —        27,942       10,561      (1,169 )     37,334  

INTEREST PAYABLE TO AFFILIATES

     —        7,612       3,549      —         11,161  

NOTES PAYABLE TO AFFILIATES

     —        26,951       12,366      —         39,317  

BANK NOTES PAYABLE, net of current portion

     —        43,576       6,600      —         50,176  

SENIOR SUBORDINATED NOTES PAYABLE

     —        115,000       —        —         115,000  

MANDATORILY REDEEMABLE PREFERRED STOCK

     —        58,098       —        —         58,098  

OTHER NON-CURRENT LIABILITIES

     671      215       2,071      (720 )     2,237  
    

  


 

  


 


Total liabilities

     671      279,394       35,147      (1,889 )     313,323  

STOCKHOLDERS’ EQUITY (DEFICIT)

     2,463      (162,257 )     28,178      (33,940 )     (165,556 )
    

  


 

  


 


     $ 3,134    $ 117,137     $ 63,325    $ (35,829 )   $ 147,767  
    

  


 

  


 


 

8


RIVER HOLDING CORP. AND SUBSIDIARIES

GUARANTOR AND NON-GUARANTOR SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEETS

 

ASSETS

 

     December 31, 2003

     River

   Guarantor

  

Non-

Guarantor


   Eliminations

    Total

CURRENT ASSETS:

                                   

Cash

   $ —      $ 3,690    $ 2,992    $ —       $ 6,682

Accounts receivable

     —        17,938      7,169      —         25,107

Intercompany receivables, net

     —        —        1,694      (1,694 )     —  

Inventories

     —        20,419      4,605      (1,195 )     23,829

Other current assets

     —        1,587      918      —         2,505
    

  

  

  


 

Total current assets

     —        43,634      17,378      (2,889 )     58,123

PROPERTY, PLANT AND EQUIPMENT, NET

     3,677      35,480      1,997      —         41,154

GOODWILL

     —        —        41,410      —         41,410

DEFERRED FINANCING AND OTHER ASSETS, net

     —        6,457      —        —         6,457

INVESTMENT IN NON-GUARANTOR SUBSIDIARIES, at cost

     —        28,636      4,000      (32,636 )     —  

OTHER ASSETS

     13      1,216      27      (720 )     536
    

  

  

  


 

Total other assets

     13      36,309      45,437      (33,356 )     48,403
    

  

  

  


 

     $ 3,690    $ 115,423    $ 64,812    $ (36,245 )   $ 147,680
    

  

  

  


 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

CURRENT LIABILITIES:

                                      

Current portion of bank notes payable

   $ —      $ 3,680     $ 5,498    $ —       $ 9,178  

Accounts payable

     —        7,170       2,005      —         9,175  

Intercompany payables, net

     —        1,694       —        (1,694 )     —    

Accrued liabilities

     —        13,459       3,514      —         16,973  
    

  


 

  


 


Total current liabilities

     —        26,003       11,017      (1,694 )     35,326  

INTEREST PAYABLE TO AFFILIATES

     —        6,720       3,040      —         9,760  

NOTES PAYABLE TO AFFILIATES

     —        26,951       12,366      —         39,317  

BANK NOTES PAYABLE, net of current portion

     —        46,552       7,825      —         54,377  

SENIOR SUBORDINATED NOTES PAYABLE

     —        115,000       —        —         115,000  

MANDATORILY REDEEMABLE PREFERRED STOCK

     —        56,480       —        —         56,480  

OTHER NON-CURRENT LIABILITIES

     671      229       2,136      (720 )     2,316  
    

  


 

  


 


Total liabilities

     671      277,935       36,384      (2,414 )     312,576  

STOCKHOLDERS’ EQUITY (DEFICIT)

     3,019      (162,512 )     28,428      (33,831 )     (164,896 )
    

  


 

  


 


     $ 3,690    $ 115,423     $ 64,812    $ (36,245 )   $ 147,680  
    

  


 

  


 


 

9


RIVER HOLDING CORP. AND SUBSIDIARIES

GUARANTOR AND NON-GUARANTOR SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS

 

     Three Months Ended March 31, 2004

     River

    Guarantor

   

Non-

Guarantor


   Eliminations

    Total

NET SALES

   $ —       $ 42,514     $ 12,399    $ (4,730 )   $ 50,183

COST OF SALES

     556       25,289       5,562      (4,621 )     26,786
    


 


 

  


 

Gross Profit

     (556 )     17,225       6,837      (109 )     23,397

OPERATING EXPENSES:

                                     

Distribution, selling, general and administrative

     —         10,159       3,947      —         14,106

Research and development

     —         536       323      —         859
    


 


 

  


 

       —         10,695       4,270      —         14,965
    


 


 

  


 

(Loss) income from operations

     (556 )     6,530       2,567      (109 )     8,432

INTEREST EXPENSE AND OTHER, net:

     —         6,295       785      —         7,080
    


 


 

  


 

(Loss) income before provision for income taxes

     (556 )     235       1,782      (109 )     1,352

PROVISION FOR INCOME TAXES

     —         (32 )     706      —         674
    


 


 

  


 

Net (loss) income

   $ (556 )   $ 267     $ 1,076    $ (109 )   $ 678
    


 


 

  


 

 

     Three Months Ended March 31, 2003

 
     River

    Guarantor

   

Non-

Guarantor


   Eliminations

    Total

 

NET SALES

   $ —       $ 40,320     $ 10,009    $ (4,450 )   $ 45,879  

COST OF SALES

     556       25,540       4,892      (4,402 )     26,586  
    


 


 

  


 


Gross Profit

     (556 )     14,780       5,117      (48 )     19,293  

OPERATING EXPENSES:

                                       

Distribution, selling, general and administrative

     —         9,744       3,013      —         12,757  

Research and development

     —         358       282      —         640  
    


 


 

  


 


       —         10,102       3,295      —         13,397  
    


 


 

  


 


(Loss) income from operations

     (556 )     4,678       1,822      (48 )     5,896  

INTEREST EXPENSE AND OTHER, net:

     —         4,605       656      —         5,261  
    


 


 

  


 


(Loss) income before provision for income taxes

     (556 )     73       1,166      (48 )     635  

PROVISION FOR INCOME TAXES

     —         165       516      —         681  
    


 


 

  


 


Net (loss) income

   $ (556 )   $ (92 )   $ 650    $ (48 )   $ (46 )
    


 


 

  


 


 

10


RIVER HOLDING CORP. AND SUBSIDIARIES

GUARANTOR AND NON-GUARANTOR SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

 

     Three Months Ended March 31, 2004

 
     River

   Guarantor

   

Non-

Guarantor


    Total

 

Net cash provided by operating activities

   $  —      $ 5,808     $ 668     $ 6,476  

Net cash used in investing activities

     —        (2,628 )     (394 )     (3,022 )

Net cash used in financing activities

     —        (2,971 )     (952 )     (3,923 )

Effect of exchange rate changes on cash

     —        (12 )     98       86  
    

  


 


 


NET INCREASE (DECREASE) IN CASH

     —        197       (580 )     (383 )

CASH, beginning of period

     —        3,690       2,992       6,682  
    

  


 


 


CASH, end of period

   $ —      $ 3,887     $ 2,412     $ 6,299  
    

  


 


 


     Three Months Ended March 31, 2003

 
     River

   Guarantor

   

Non-

Guarantor


    Total

 

Net cash provided by operating activities

   $  —      $ 6,485     $ 520     $ 7,005  

Net cash used in investing activities

     —        (1,566 )     (140 )     (1,706 )

Net cash used in provided by financing activities

     —        (5,563 )     (602 )     (6,165 )

Effect of exchange rate changes on cash

     —        6       (298 )     (292 )
    

  


 


 


NET DECREASE IN CASH

     —        (638 )     (520 )     (1,158 )

CASH, beginning of period

     —        3,568       2,857       6,425  
    

  


 


 


CASH, end of period

   $ —      $ 2,930     $ 2,337     $ 5,267  
    

  


 


 


 

4. Commitments and Contingencies. Holding is not a party to any material lawsuits or other proceedings. While the result of Holding’s other existing lawsuits and proceedings cannot be predicted with certainty, management does not expect that the ultimate resolution of these matters will have a material adverse effect on the financial position or results of operations of the Company.

 

Self Insurance. Holding self-insures the majority of its medical benefit programs and workers’ compensation whereby Holding directly assumes the liability for employee medical and dental claims presented, subject to per-claim and aggregate maximums. Reserves for medical claim losses (including retiree benefits) totaling approximately $0.9 million and $1.1 million at March 31, 2004 and December 31, 2003, respectively, were established based upon estimated obligations and are included in accrued liabilities in the accompanying unaudited condensed consolidated balance sheets. Holding maintains excess coverage on an aggregate claim basis. Additionally, Holding is self-insured for workers’ compensation. Reserves for workers’ compensation claim losses totaling approximately $0.9 million and $0.8 million at March 31, 2004 and December 31, 2003, respectively, were established based upon estimated obligations and are included in accrued liabilities in the accompanying unaudited condensed consolidated balance sheets. Holding maintains excess coverage on an individual and aggregate claim basis. A third-party administrator processes all employee medical claims and requires Holding to collateralize a portion of its potential payment liability through the use of standby letters of credit. The standby letters of credit are issued for one-year periods with automatic annual extensions until such time the third-party administrator determines all outstanding claims for the policy period have been paid. As of March 31, 2004, Holding had issued three such standby letters of credit totaling approximately $1.6 million.

 

5. Bank Notes Payable. Total borrowings as of March 31, 2004 were $59.1 million, which consisted of $17.2 million under the Revolving A Facility, $30.0 million under the Term B Facility and $11.9 million under the HRCI AB Facility. As of March 31, 2004, $11.7 million was available for borrowing. As of March 31, 2004, the fair value of the bank notes payable approximated the face value.

 

At March 31, 2004, Holding was in compliance with all provisions of its debt securities.

 

11


6. Mandatorily Redeemable Preferred Stock. At March 31, 2004 the redemption amount was $58.5 million, of which $55.6 million relates to issued shares and $2.9 million to accrued but not issued shares. The maximum amount the Company will pay on April 15, 2010, the mandatory redemption date will be $115.0 million and will be accreted at a rate per annum of 11 ½% with dividends being paid in kind and not in cash.

 

7. Subsidiary Financials. Because Holding is a holding company with no operations other than those of the Company, the unaudited condensed financial statements of the Company have been included.

 

HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

(A majority-owned subsidiary of River Holding Corp.)

 

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

 

ASSETS

 

(amounts in thousands)

 

    

March 31,

2004


  

December 31,

2003


CURRENT ASSETS:

             

Cash

   $ 6,299    $ 6,682

Accounts receivable, less allowance for doubtful accounts of $1,217 and $1,156 at March 31, 2004 and December 31, 2003, respectively

     27,319      25,107

Inventories, net

     24,074      23,829

Other current assets

     2,455      2,505
    

  

Total current assets

     60,147      58,123

PROPERTY, PLANT AND EQUIPMENT, net

     37,927      37,477

GOODWILL

     39,822      41,410

DEFERRED FINANCING AND OTHER COSTS, net of accumulated amortization of $5,457 and $5,188 at March 31, 2004 and December 31, 2003, respectively

     6,169      6,457

OTHER ASSETS

     1,288      1,243
    

  

Total other assets

     47,279      49,110
    

  

Total assets

   $ 145,353    $ 144,710
    

  

 

See notes to condensed consolidated statements

 

12


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

(A majority-owned subsidiary of River Holding Corp.)

 

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

(amounts in thousands, except per share amounts)

 

    

March 31,

2004


   

December 31,

2003


 

CURRENT LIABILITIES:

                

Current portion of bank notes payable

   $ 8,968     $ 9,178  

Accounts payable

     10,652       9,175  

Accrued liabilities

     17,714       16,973  
    


 


Total current liabilities

     37,334       35,326  

INTEREST PAYABLE TO AFFILIATES

     11,161       9,760  

NOTES PAYABLE TO AFFILIATES

     39,317       39,317  

BANK NOTES PAYABLE, net of current portion

     50,176       54,377  

SENIOR SUBORDINATED NOTES PAYABLE

     115,000       115,000  

MANDATORILY REDEEMABLE PREFERRED STOCK, $0.01 par value; 2,990 shares authorized; 556 shares issued and outstanding at March 31, 2004 and December 31, 2003; liquidation preference, $58,550

     55,166       55,147  

Accrued preferred stock dividend, payable in kind

     2,932       1,333  
    


 


       58,098       56,480  

OTHER NON-CURRENT LIABILITIES

     2,286       2,365  
    


 


Total liabilities

     313,372       312,625  

COMMITMENTS AND CONTINGENCIES (Note 4)

                

STOCKHOLDERS’ DEFICIT:

                

Junior preferred stock, $0.01 par value; 10 shares authorized; 3 shares outstanding at March 31, 2004 and December 31, 2003

     4,076       3,960  

Common stock, $0.01 par value; 42,000 shares authorized; 10,654 issued and outstanding at March 31, 2004 and December 31, 2003

     98,258       98,258  

Additional paid in capital

     881       881  

Cumulative translation adjustment

     5,509       6,848  

Accumulated deficit

     (276,743 )     (277,862 )
    


 


Total stockholders’ deficit

     (168,019 )     (167,915 )
    


 


Total liabilities and stockholders’ deficit

   $ 145,353     $ 144,710  
    


 


 

See notes to condensed consolidated statements

 

13


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

(A majority-owned subsidiary of River Holding Corp.)

 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(amounts in thousands)

 

     Three Months Ended

    

March 31,

2004


   

March 31,

2003


NET SALES

   $ 50,183     $ 45,879

COST OF SALES

     26,230       26,030
    


 

Gross Profit

     23,953       19,849

OPERATING EXPENSES:

              

Distribution, selling, general & administrative

     14,106       12,757

Research and development

     859       640
    


 

       14,965       13,397
    


 

Income from operations

     8,988       6,452

INTEREST EXPENSE AND OTHER, net

     7,080       5,261
    


 

Net income before provision for income taxes

     1,908       1,191

PROVISION FOR INCOME TAXES

     674       681
    


 

Net income

   $ 1,234     $ 510
    


 

OTHER COMPREHENSIVE INCOME (LOSS):

              

Foreign currency translation (loss) gain

     (1,339 )     721
    


 

Comprehensive (loss) income

   $ (105 )   $ 1,231
    


 

 

See notes to condensed consolidated statements

 

14


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

(A majority-owned subsidiary of River Holding Corp.)

 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

(amounts in thousands)

 

     Three Months Ended

 
    

March 31,

2004


   

March 31,

2003


 

CASH FLOWS FROM OPERATING ACTIVITIES:

                

Net income

   $ 1,234     $ 510  

Adjustments to reconcile net income to net cash provided by operating activities—  

                

Depreciation and amortization

     2,481       2,405  

Amortization of deferred financing costs

     269       464  

Accrued mandatorily redeemable preferred stock dividends, payable in-kind

     1,618       —    

Interest payable to affiliates

     1,402       1,064  

Provision for bad debts

     88       197  

Loss (gain) on disposal of property, plant and equipment

     11       (6 )

Changes in operating assets and liabilities:

                

Accounts receivable

     (2,618 )     342  

Inventories

     (422 )     1,413  

Other current assets

     13       (799 )

Other assets

     (46 )     (19 )

Accounts payable

     1,543       (625 )

Accrued liabilities

     885       2,047  

Other non-current liabilities

     18       12  
    


 


Net cash provided by operating activities

     6,476       7,005  

CASH FLOWS FROM INVESTING ACTIVITIES:

                

Purchases of property, plant and equipment

     (3,024 )     (1,723 )

Proceeds from sales of property, plant and equipment

     2       17  
    


 


Net cash used in investing activities

     (3,022 )     (1,706 )

CASH FLOWS FROM FINANCING ACTIVITIES:

                

Repayment of bank notes payable

     (4,317 )     (7,734 )

Proceeds from bank borrowings

     408       1,582  

Payment of capital lease obligations

     (14 )     (13 )
    


 


Net cash used in financing activities

     (3,923 )     (6,165 )

Effect of exchange rate changes on cash

     86       (292 )
    


 


NET DECREASE IN CASH

     (383 )     (1,158 )

CASH, beginning of period

     6,682       6,425  
    


 


CASH, end of period

   $ 6,299     $ 5,267  
    


 


 

See notes to condensed consolidated statements

 

15


     Three Months Ended

    

March 31,

2004


  

March 31,

2003


SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

             

Cash paid during the period for:

             

Interest

   $ 932    $ 1,076
    

  

Income taxes (primarily foreign)

   $ 365    $ 1,138
    

  

NON-CASH FINANCING ACTIVITIES:

             

Preferred dividends accrued or paid-in-kind

   $ 116    $ 1,533
    

  

 

See notes to condensed consolidated statements

 

16


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

(A majority-owned subsidiary of River Holding Corp.)

 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. Financial Statements. The condensed consolidated financial statements included herein have been prepared by the Company, without audit, and include all adjustments which are, in the opinion of management, necessary for a fair presentation of the financial position at March 31, 2004, the results of operations for the three month periods ended March 31, 2004 and March 31, 2003 and statements of cash flows for the three month periods ended March 31, 2004 and March 31, 2003 pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. Although the Company believes that the disclosures in such financial statements are adequate to make the information presented not misleading, the accompanying unaudited condensed, consolidated financial statements should be read in conjunction with the Company’s 2003 audited financial statements and the notes thereto included in its Form 10-K filed with the SEC. The results of operations for the three month period ended March 31, 2004 are not necessarily indicative of the results to be achieved for a full year.

 

Significant Accounting Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

The significant estimates made in the preparation of the Company’s consolidated financial statements relate to allowance for bad debts, rebate reserve, and inventory reserve.

 

Stock Based Compensation

 

The Company accounts for its stock-based compensation plans under the recognition and measurement principles of Accounting Principles Board Opinion (“APB”) No. 25, “Accounting for Stock Issued to Employees,” and related interpretations. The Company has adopted the disclosure provisions of SFAS 123, “Accounting for Stock-Based Compensation,” as amended by SFAS 148, “Accounting for Stock-Based Compensation – Transition and Disclosure – an amendment of FASB Statement No. 123.” No stock-based employee compensation expense is recognized in net income for any of the periods presented. Had compensation expense for the Company’s stock-based compensation awards been recognized based on the fair value recognition provisions of SFAS 123, the Company’s net income would have been adjusted to the pro forma amounts indicated below (amounts in thousands):

 

     Three Months Ended March 31,

     2004

   2003

Net income, as reported

   $ 1,234    $ 510

Deduct: Total stock-based employee compensation expense determined under the fair value based method for all awards

     33      3
    

  

Pro forma net income

   $ 1,201    $ 507
    

  

 

Under the fair-value method, compensation expense is measured at the grant date based on the fair value of the award using an option-pricing model. Compensation expense is recognized on a straight-line basis over the vesting period. The fair value of employee stock options was estimated using the Black-Scholes option-pricing model with the following weighted-average assumptions used for grants in 2003 and 2002: risk-free interest rates of

 

17


2.00% and 2.83%, respectively; dividend yield of 0% for all years; expected lives of three years and four years, respectively, and volatility of 50% for both years.

 

Reclassifications

 

Certain amounts from prior periods have been reclassified to conform to the current period presentation.

 

2. Inventories. Inventories consisted of the following (amounts in thousands):

 

    

March 31,

2004


  

December 31,

2003


Raw materials

   $ 4,587    $ 4,558

Work-in-process

     5,113      4,955

Finished goods

     14,374      14,316
    

  

     $ 24,074    $ 23,829
    

  

 

3. Geographic and Segment Information. The Company presents segment information externally based on how management uses financial data internally to make operating decisions and assess performance. The Company has two operating segments: guarantor, primarily the United States and non-guarantor, primarily international. The non-guarantor subsidiaries consist principally of Hudson AB and subsidiaries (whose operations are principally international). Under SFAS 131, “Disclosures about Segments of an Enterprise and Related Information,” the Company’s operating segments are the same as its reporting segments.

 

The Company sells respiratory care and anesthesia products to distributors and medical facilities throughout the United States and internationally. Operating results of the Company’s various product groups have been aggregated because of their common characteristics and their reliance on shared operating functions. The Company operates primarily in the United States and in Europe.

 

The Company’s sales and percentage of sales by geographic region for the three months ending March 31, 2004 and 2003 are as follows (amounts in thousands):

 

     Three Months Ended

 
     March 31, 2004

    March 31, 2003

 

United States

   $ 34,454    68.6 %   $ 33,573    73.2 %

Europe

     9,824    19.6       7,052    15.4  

Pacific Rim (Japan, Southeast Asia, Australia/New Zealand)

     3,140    6.3       3,355    7.3  

Canada

     794    1.6       564    1.2  

Other international

     1,971    3.9       1,335    2.9  
    

  

 

  

     $ 50,183    100.0 %   $ 45,879    100.0 %
    

  

 

  

 

The Company’s sales and percentage of sales by product group for the three months ending March 31, 2004, and 2003 are as follows (amounts in thousands):

 

     Three Months Ended

 
     March 31, 2004

    March 31, 2003

 

Oxygen Therapy

   $ 14,897    29.7 %   $ 13,264    28.9 %

Airway Management

     11,834    23.6       11,803    25.7  

Humidification

     11,464    22.8       10,676    23.3  

Aerosol Therapy

     11,987    23.9       10,136    22.1  
    

  

 

  

     $ 50,183    100.0 %   $ 45,879    100.0 %
    

  

 

  

 

The Company is the 100% owner of certain subsidiaries that do not guarantee the Company’s senior subordinated notes and certain bank debt. The following tables disclose required consolidating financial information for

 

18


guarantor and non-guarantor subsidiaries (amounts in thousands):

 

HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

GUARANTOR AND NON-GUARANTOR SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET

 

ASSETS  
     March 31, 2004

 
     Guarantor

   

Non-

Guarantor


   Eliminations

    Total

 

CURRENT ASSETS:

                               

Cash

   $ 3,887     $ 2,412    $ —       $ 6,299  

Accounts receivable

     18,897       8,422      —         27,319  

Intercompany receivables, net

     —         1,169      (1,169 )     —    

Inventories

     20,946       4,432      (1,304 )     24,074  

Other current assets

     1,499       956      —         2,455  
    


 

  


 


Total current assets

     45,229       17,391      (2,473 )     60,147  

PROPERTY, PLANT AND EQUIPMENT, NET

     35,841       2,086      —         37,927  

GOODWILL

     —         39,822      —         39,822  

DEFERRED FINANCING COSTS, net

     6,169       —        —         6,169  

INVESTMENT IN NON-GUARANTOR SUBSIDIARIES, at cost

     28,636       4,000      (32,636 )     —    

OTHER ASSETS

     1,262       26      —         1,288  
    


 

  


 


Total other assets

     36,067       43,848      (32,636 )     47,279  
    


 

  


 


     $ 117,137     $ 63,325    $ (35,109 )   $ 145,353  
    


 

  


 


LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)  

CURRENT LIABILITIES:

                               

Current portion of bank notes payable

   $ 3,680     $ 5,288    $ —       $ 8,968  

Accounts payable

     9,098       1,554      —         10,652  

Intercompany payables, net

     1,169       —        (1,169 )     —    

Accrued liabilities

     13,995       3,719      —         17,714  
    


 

  


 


Total current liabilities

     27,942       10,561      (1,169 )     37,334  

INTEREST PAYABLE TO AFFILIATES

     7,612       3,549      —         11,161  

NOTES PAYABLE TO AFFILIATES

     26,951       12,366      —         39,317  

BANK NOTES PAYABLE, net of current portion

     43,576       6,600      —         50,176  

SENIOR SUBORDINATED NOTES PAYABLE

     115,000       —        —         115,000  

MANDATORILY REDEEMBABLE PREFERRED STOCK

     58,098       —        —         58,098  

OTHER NON-CURRENT LIABILITIES

     215       2,071      —         2,286  
    


 

  


 


Total liabilities

     279,394       35,147      (1,169 )     313,372  

STOCKHOLDERS’ EQUITY (DEFICIT)

     (162,257 )     28,178      (33,940 )     (168,019 )
    


 

  


 


     $ 117,137     $ 63,325    $ (35,109 )   $ 145,353  
    


 

  


 


 

19


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

GUARANTOR AND NON-GUARANTOR SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET

 

ASSETS  
     December 31, 2003

 
     Guarantor

   

Non-

Guarantor


   Eliminations

    Total

 

CURRENT ASSETS:

                               

Cash

   $ 3,690     $ 2,992    $ —       $ 6,682  

Accounts receivable

     17,938       7,169      —         25,107  

Intercompany receivables, net

     —         1,694      (1,694 )     —    

Inventories

     20,419       4,605      (1,195 )     23,829  

Other current assets

     1,587       918      —         2,505  
    


 

  


 


Total current assets

     43,634       17,378      (2,889 )     58,123  

PROPERTY, PLANT AND EQUIPMENT, NET

     35,480       1,997      —         37,477  

GOODWILL

     —         41,410      —         41,410  

DEFERRED FINANCING COSTS, net

     6,457       —        —         6,457  

INVESTMENT IN NON-GUARANTOR SUBSIDIARIES, at cost

     28,636       4,000      (32,636 )     —    

OTHER ASSETS

     1,216       27      —         1,243  
    


 

  


 


Total other assets

     36,309       45,437      (32,636 )     49,110  
    


 

  


 


     $ 115,423     $ 64,812    $ (35,525 )   $ 144,710  
    


 

  


 


LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)  

CURRENT LIABILITIES:

                               

Current portion of bank notes payable

   $ 3,680     $ 5,498    $ —       $ 9,178  

Accounts payable

     7,170       2,005      —         9,175  

Intercompany payables, net

     1,694       —        (1,694 )     —    

Accrued liabilities

     13,459       3,514      —         16,973  
    


 

  


 


Total current liabilities

     26,003       11,017      (1,694 )     35,326  

INTEREST PAYABLE TO AFFILIATES

     6,720       3,040      —         9,760  

NOTES PAYABLE TO AFFILIATES

     26,951       12,366      —         39,317  

BANK NOTES PAYABLE, net of current portion

     46,552       7,825      —         54,377  

SENIOR SUBORDINATED NOTES PAYABLE

     115,000       —        —         115,000  

MANDATORILY REDEEMABLE PREFERRED STOCK

     56,480       —        —         56,480  

OTHER NON-CURRENT LIABILITIES

     229       2,136      —         2,365  
    


 

  


 


Total liabilities

     277,935       36,384      (1,694 )     312,625  

STOCKHOLDERS’ EQUITY (DEFICIT)

     (162,512 )     28,428      (33,831 )     (167,915 )
    


 

  


 


     $ 115,423     $ 64,812    $ (35,525 )   $ 144,710  
    


 

  


 


 

20


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

GUARANTOR AND NON-GUARANTOR SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

 

     Three Months Ended March 31, 2004

     Guarantor

   

Non-

Guarantor


   Eliminations

    Total

NET SALES

   $ 42,514     $ 12,399    $ (4,730 )   $ 50,183

COST OF SALES

     25,289       5,562      (4,621 )     26,230
    


 

  


 

Gross Profit

     17,225       6,837      (109 )     23,953

OPERATING EXPENSES:

                             

Distribution, selling, general and administrative

     10,159       3,947      —         14,106

Research and development

     536       323      —         859
    


 

  


 

       10,695       4,270      —         14,965
    


 

  


 

Income from operations

     6,530       2,567      (109 )     8,988

INTEREST EXPENSE AND OTHER, net:

     6,295       785              7,080
    


 

  


 

Income before provision for income taxes

     235       1,782      (109 )     1,908

(BENEFIT) PROVISION FOR INCOME TAXES

     (32 )     706      —         674
    


 

  


 

Net income

   $ 267     $ 1,076    $ (109 )   $ 1,234
    


 

  


 

     Three Months Ended March 31, 2003

     Guarantor

   

Non-

Guarantor


   Eliminations

    Total

NET SALES

   $ 40,320     $ 10,009    $ (4,450 )   $ 45,879

COST OF SALES

     25,540       4,892      (4,402 )     26,030
    


 

  


 

Gross Profit

     14,780       5,117      (48 )     19,849

OPERATING EXPENSES:

                             

Distribution, selling, general and administrative

     9,744       3,013      —         12,757

Research and development

     358       282      —         640
    


 

  


 

       10,102       3,295      —         13,397
    


 

  


 

Income from operations

     4,678       1,822      (48 )     6,452

INTEREST EXPENSE AND OTHER, net:

     4,605       656              5,261
    


 

  


 

Income (loss) before provision for income taxes

     73       1,166      (48 )     1,191

PROVISION FOR INCOME TAXES

     165       516      —         681
    


 

  


 

Net (loss) income

   $ (92 )   $ 650    $ (48 )   $ 510
    


 

  


 

 

21


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

GUARANTOR AND NON-GUARANTOR SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

 

     Three Months Ended March 31, 2004

 
     Guarantor

   

Non-

Guarantor


    Total

 

Net cash provided by operating activities

   $ 5,808     $ 668     $ 6,476  

Net cash used in investing activities

     (2,628 )     (394 )     (3,022 )

Net cash used in financing activities

     (2,971 )     (952 )     (3,923 )

Effect of exchange rate changes on cash

     (12 )     98       86  
    


 


 


NET INCREASE (DECREASE) IN CASH

     197       (580 )     (383 )

CASH, beginning of period

     3,690       2,992       6,682  
    


 


 


CASH, end of period

   $ 3,887     $ 2,412     $ 6,299  
    


 


 


     Three Months Ended March 31, 2003

 
     Guarantor

   

Non-

Guarantor


    Total

 

Net cash provided by operating activities

   $ 6,485     $ 520     $ 7,005  

Net cash used in investing activities

     (1,566 )     (140 )     (1,706 )

Net cash used in financing activities

     (5,563 )     (602 )     (6,165 )

Effect of exchange rate changes on cash

     6       (298 )     (292 )
    


 


 


NET DECREASE IN CASH

     (638 )     (520 )     (1,158 )

CASH, beginning of period

     3,568       2,857       6,425  
    


 


 


CASH, end of period

   $ 2,930     $ 2,337     $ 5,267  
    


 


 


 

4. Commitments and Contingencies. The Company is not a party to any material lawsuits or other proceedings. While the result of the Company’s other existing lawsuits and proceedings cannot be predicted with certainty, management does not expect that the ultimate resolution of these matters will have a material adverse effect on the financial position or results of operations of the Company.

 

Self Insurance. The Company self-insures the majority of its medical benefit programs and workers’ compensation whereby the Company directly assumes the liability for employee medical and dental claims presented, subject to per-claim and aggregate maximums. Reserves for medical claim losses (including retiree benefits) totaling approximately $0.9 million and $1.1 million at March 31, 2004 and December 31, 2003, respectively, were established based upon estimated obligations and are included in accrued liabilities in the accompanying unaudited condensed consolidated balance sheets. The Company maintains excess coverage on an aggregate claim basis. Additionally, the Company is self-insured for workers’ compensation. Reserves for workers’ compensation claim losses totaling approximately $0.9 million and $0.8 million at March 31, 2004 and December 31, 2003, respectively, were established based upon estimated obligations and are included in accrued liabilities in the accompanying unaudited condensed consolidated balance sheets. The Company maintains excess coverage on an individual and aggregate claim basis. A third-party administrator processes all employee medical claims and requires the Company to collateralize a portion of its potential payment liability through the use of standby letters of credit. The standby letters of credit are issued for one-year periods with automatic annual extensions until such time the third-party administrator determines all outstanding claims for the policy period have been paid. As of March 31, 2004, the Company had issued three such standby letters of credit totaling approximately $1.6 million.

 

5. Bank Notes Payable. Total borrowings as of March 31, 2004 were $59.1 million, which consisted of $17.2 million under the Revolving A Facility, $30.0 million under the Term B Facility and $11.9 million under the HRCI AB Facility. As of March 31, 2004, $11.7 million was available for borrowing. As of March 31, 2004, the fair value of the bank notes payable approximated the face value.

 

At March 31, 2004, the Company was in compliance with all provisions of its debt securities.

 

22


6. Mandatorily Redeemable Preferred Stock. At March 31, 2004 the redemption amount was $58.5 million, of which $55.6 million relates to issued shares and $2.9 million to accrued but not issued shares. The maximum amount the Company will pay on April 15, 2010, the mandatory redemption date will be $115.0 million and will be accreted at a rate per annum of 11 ½% with dividends being paid in kind and not in cash.

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Because River Holding Corp. (“Holding”) is a holding company with no operations other than those of Hudson Respiratory Care Inc. (the “Company” or “Hudson”), the following discussion throughout this section relates primarily to the Company. The following discussion of Holding and the Company’s consolidated historical results of operations and financial condition should be read in conjunction with the consolidated financial statements of Holding and the Company and the notes thereto included elsewhere in this Form 10-Q and the 2003 Form 10-K.

 

Holding’s acquisition of a majority of the Company’s stock was accounted for as a purchase. As a result of Holding’s acquisition of the Company, Holding recorded property, plant and equipment at fair value. Additional depreciation expense related to the allocation of purchase price at fair value to depreciable assets of $0.6 million was recorded in the first three months of 2004 and 2003. The remaining value of the step-up in basis to fair value was approximately $3.1 million at March 31, 2004.

 

There are no other material differences between Holding consolidated and the Company.

 

Forward-Looking Statements

 

This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains certain “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. Such statements relating to future events and financial performance are forward-looking statements involving risks and uncertainties that are detailed from time to time in the Company’s Securities and Exchange Commission filings.

 

General

 

The Company manufactures and markets products for use in respiratory care and anesthesia. The products for each market are similar and often overlap, as do the distribution channels. The Company categorizes its products into four clinical product groups: (i) oxygen therapy; (ii) airway management; (iii) humidification; and (iv) aerosol therapy. Although the Company’s sales efforts differ depending on the clinical use of its products, management focuses on geographic segments for strategic decision making.

 

Category

  

Examples of Products


Oxygen Therapy    Oxygen masks, cannulae, oxygen tubing, prefilled and refillable humidifiers, oxygen regulators, cylinder carts and bases, oxygen analyzers/monitors, oxygen sensors, and adaptors and connectors
Airway Management    Oral airways, SHERIDAN® endotracheal tubes, Voldyne® incentive breathing exercisers (IBEs), disposable and re-useable resuscitation bags, hyperinflation bags, breathing bags, air cushion masks, anesthesia circuits, filters and Ventilarm® monitors
Humidification    ConchaTherm® heated humidifiers and accessories, Humid-Heat® system and accessories, Concha® water, ConchaPak®, Aqua+® and Humid-Vent® HMEs, volume ventilator circuits, heated wire circuits, neonatal CPAP and CPAP heated humidifiers
Aerosol Therapy    AquaTherm® and ThermaGard® nebulizer heaters, aerosol masks, prefilled and refillable large volume nebulizers, aerosol tubing, unit dose solutions, small volume nebulizers, peak flow meters, spacers/changers and compressor accessories

 

23


The Company’s results of operations may fluctuate significantly from quarter to quarter as a result of a number of factors, including, among others, (i) the buying patterns of the Company’s distributors, group purchasing organizations (“GPOs”) and other purchasers of the Company’s products, (ii) forecasts regarding the severity of the annual cold and flu season, (iii) announcements of new product introductions by the Company or its competitors, (iv) changes in the Company’s pricing of its products and the prices offered by the Company’s competitors and (v) variability in the number of shipping days in a given quarter.

 

Results of Operations

 

The following tables set forth, for the periods indicated, certain income and expense items expressed in dollars and as a percentage of the Company’s net sales.

 

     Three Months Ended March 31,

 
     2004

    2003

 
     (dollars in thousands)  

Net sales

   $ 50,183     $ 45,879  

Cost of sales

     26,230       26,030  
    


 


Gross profit

     23,953       19,849  
    


 


Distribution expenses

     3,047       2,356  

Selling expenses

     5,890       5,458  

General and administrative expenses

     5,169       4,943  

Research and development expenses

     859       640  
    


 


Total operating expenses

     14,965       13,397  
    


 


Income from operations

     8,988       6,452  

Interest expense and other, net

     7,080       5,261  
    


 


Net income before provision for income taxes

     1,908       1,191  

Provision for income taxes

     674       681  
    


 


Net income

   $ 1,234     $ 510  
    


 


     Three Months Ended March 31,

 
     2004

    2003

 

Net sales

     100.0 %     100.0 %

Cost of sales

     52.3       56.7  
    


 


Gross profit

     47.7       43.3  
    


 


Distribution expenses

     6.1       5.1  

Selling expenses

     11.7       11.9  

General and administrative expenses

     10.3       10.8  

Research and development expenses

     1.7       1.4  
    


 


Total operating expenses

     29.8       29.2  
    


 


Income from operations

     17.9       14.1  

Interest expense and other, net

     14.1       11.5  
    


 


Net income before provision for income taxes

     3.8       2.6  

Provision for income taxes

     1.3       1.5  
    


 


Net income

     2.5 %     1.1 %
    


 


 

24


Three Months Ended March 31, 2004 Compared to Three Months Ended March 31, 2003

 

Net sales were $50.2 million in the first quarter of 2004 as compared to $45.9 million in the first quarter of 2003, representing an increase of $4.3 million or 9.4%. This increase was driven by sales into the European market which increased by $2.8 million equally attributable to favorable changes in exchange rates and greater volume; sales into the U.S. which were up $0.9 million primarily due to greater volume; and sales into Latin America which increased by $0.6 million primarily due to greater volume. Overall, sales increased from greater unit volume of $2.9 million, the impact of favorable changes in exchange rates resulting from a weakened U.S. dollar of $1.2 million and increases in prices of $0.2 million.

 

Sales of Aerosol Therapy products increased by $1.9 million due to greater volume into the U.S and Europe and favorable changes in exchange rates from sales into Europe ($0.2 million). Sales of Oxygen Therapy products increased by $1.6 million due to greater volume into Europe and the U.S and favorable changes in exchange rates from sales into Europe ($0.4 million). Sales of Humidification products increased by $0.8 million equally attributable to greater volume into Latin America and favorable changes in exchange rates from sales into Europe. Sales of Airway Management products were relatively unchanged with the impact of favorable changes in exchange rates of $0.2 million from sales into Europe, offset by a slight decrease in volume of $0.2 million.

 

The Company’s gross profit for the first quarter of 2004 was $24.0 million, an increase of $4.1 million or 20.7% from the first quarter of 2003. As a percentage of sales, the gross profit was 47.7% and 43.3% for the first quarter of 2004 and 2003, respectively. The increase in gross profit was attributable to greater sales volume of $1.1 million primarily in the European market, the favorable impact of the weakening value of the U.S. Dollar as compared to other countries’ currencies in which the Company distributes its products ($1.0 million or 0.6 margin points) and lower manufacturing costs ($2.0 million or 3.8 margin points). The $2.0 million reduction in manufacturing costs was driven by reduced spending associated with transition expenses related to the move of the Argyle, New York facility to Tecate, Mexico ($1.1 million or 2.0 margin points) and improvements in plant utilization ($0.9 million or 1.7 margin points). Other improvements contributed 0.1 margin point.

 

Distribution expenses were $3.0 million for the first quarter of 2004 as compared to $2.4 million in the first quarter of 2003, representing an increase of $0.6 million or 29.3%. The increase was primarily attributable to higher transportation expenses of $0.3 million, greater volume of $0.2 million and unfavorable changes in exchange rates of $0.1 million. As a percentage of sales, distribution expense was 6.1% in the first quarter of 2004 as compared to 5.1% in the first quarter of 2003.

 

Selling expenses were $5.9 million for the first quarter of 2004 as compared to $5.5 million in the first quarter of 2003, representing an increase of $0.4 million or 7.9%. The increase was primarily attributable to unfavorable changes in exchange rates of $0.3 million and other increases of $0.1 million to support the growth in sales. As a percentage of net sales, selling expenses were 11.7% in the first quarter of 2004 as compared to 11.9% in the first quarter of 2003.

 

General and administrative expenses were $5.2 million in the first quarter of 2004 as compared to $4.9 million in the first quarter of 2003, representing an increase of $0.3 million or 4.6%. The increase was attributable to unfavorable changes in exchange rates of $0.1 million and other expenses of $0.2 million. As a percentage of net sales, general and administrative expenses were 10.3% in the first quarter of 2004 as compared to 10.8% in the first quarter of 2003.

 

Interest and other expense was $7.1 million for the first quarter of 2004 as compared to $5.3 million in the first quarter of 2003, representing an increase of $1.8 million or 34.6%. The increase was primarily due to the treatment of preferred stock dividends as interest expense during 2004 (See footnote 1 on the Company’s adoption of SFAS 150).

 

25


Income tax provision was $0.7 million for the first quarter of 2004, unchanged from the first quarter of 2003 and related primarily to foreign income taxes.

 

Financial Condition, Liquidity and Capital Resources

 

The Company had working capital of $22.8 million at March 31, 2004 and December 31, 2003. Net cash provided by operating activities was $6.5 million for the three months ended March 31, 2004 as compared to $7.0 million for the three months ended March 31, 2003. The decrease in cash provided by operating activities for the current three month period was primarily due to an increase in accounts receivable and inventories compared to the prior year period.

 

Net cash used by investing activities was $3.0 million for the three months ended March 31, 2004 as compared to $1.7 million for the three months ended March 31, 2003. Cash used by investing activities for both periods includes capital expenditures, which include the purchase of leasehold improvements, production equipment, computer hardware, office equipment and the cost of equipment leased to customers.

 

Net cash used by financing activities was $3.9 million for the three months ended March 31, 2004 as compared to $6.2 million for the three months ended March 31, 2003. Cash used by financing activities for both periods resulted from repayments of long-term obligations.

 

As of March 31, 2004, the Company has issued to Holding 556,176 shares (including shares issued as payment in kind dividends) of Company Preferred Stock with an aggregate liquidation preference of $58.5 million. At the election of the Company, dividends may be paid in kind until April 15, 2005 and thereafter must be paid in cash. On April 15, 2004 the Company declared and issued 31,975 shares of Company Preferred Stock to Holding. The Revolving Facility currently prohibits the Company from paying cash dividends on Company Preferred Stock.

 

The Company believes that its sources of funding, consisting of projected positive cash flow from operating activities, the availability of additional funds under its revolving credit facility (totaling approximately $11.7 million at March 31, 2004), and its accumulated cash (totaling $6.3 million at March 31, 2004) will be sufficient to meet its current and presently anticipated short-term and long-term future needs for operating activities, investing activities, and financing activities (primarily consisting of scheduled payments on long-term debt).

 

Contractual Obligations

 

The Company has contractual financial obligations consisting primarily of long-term debt, mandatorily redeemable preferred stock, capital lease obligations and non-cancelable operating leases. As of March 31, 2004, the Company had outstanding $282.7 million of indebtedness, consisting of $115.0 million of 9 1/8% Senior Subordinated Notes due 2008, mandatorily redeemable preferred stock of $58.1 million, borrowings of $47.3 million under the Company’s Revolving Facility, $11.2 million in interest payable to affiliates, $39.3 million in notes payable to affiliates and $11.8 million in outstanding borrowings under the bank facility of Hudson RCI AB, its Swedish subsidiary.

 

At March 31, 2004, the Company was in compliance with all provisions of its debt securities and preferred stock.

 

The following is a summary of the Company’s consolidated contractual obligations as of March 31, 2004 (amounts in thousands):

 

     Payments Due by Period

     Total

  

Less Than

1 Year


  

1-3

Years


  

3-5

Years


  

After 5

Years


Long-term debt

   $ 282,719    $ 8,968    $ 6,482    $ 203,894    $ 63,375

Lease commitments

     9,618      3,011      3,086      2,224      1,297
    

  

  

  

  

Total contractual obligations

   $ 292,337    $ 11,979    $ 9,568    $ 206,118    $ 64,672
    

  

  

  

  

 

26


For additional information regarding Holding’s debt securities and preferred stock, reference is made to Item 7 of Holding’s Annual Report on Form 10-K, for the year ended December 31, 2003.

 

As Holding is a holding company, its primary source of liquidity is dividends or other distributions from the Company. Holding’s only asset is its investment in Hudson Respiratory Care, Inc. The ability of the Company to pay cash dividends or make distributions to Holding when required is restricted or prohibited under the terms of the debt instruments, including the Credit Facility. Since the Credit Agreement currently prohibits the Company from paying cash dividends to Holding, Holding may not be able to pay cash dividends to the holders of Holding Preferred Stock commencing in April 2005. In the event Holding is unable to pay cash dividends to the holders of Holding Preferred Stock for two consecutive periods, the sole remedy of the holders is the ability to elect two members to Holding’s Board of Directors.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS

 

There have been no material changes in Holding’s market risk exposure from that reported in Holding’s 10-K for the fiscal year ended December 31, 2003.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Holding’s Chief Executive Officer and Chief Financial Officer have concluded, based on an evaluation of Holding’s disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(c)), during the period covered by this report, that such disclosure controls and procedures were effective as of the end of the period covered by this report. No changes in Holding’s internal control over financial reporting occurred during the period covered by this report that have materially affected, or is reasonably likely to material affect, Holding’s internal control over financial reporting.

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 2. CHANGES IN SECURITIES

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

Not applicable.

 

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

 

(a) Exhibits

 

27


31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

(b) Current Reports on Form 8-K.

 

None.

 

28


SIGNATURE

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

       

RIVER HOLDING CORP.,

       

a Delaware corporation

May 7, 2004

     

by:

 

/s/    Patrick G. Yount        

           
            Patrick G. Yount
            Chief Financial Officer
            (Duly Authorized Officer and Principal Financial Officer)